Literature DB >> 25332585

A paroxysmal nocturnal haemoglobinuria progress with waldenström macroglobulinemia along with T cell monoclonal expansion.

Hongying Liu1, Chuan He1, Huanling Zhu1, Xianglong Li1, Chunli Yang1, Dewan Zhao1, Xiujin Wu1.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hematopoietic stem cell clinical disease, which has been reported associated with T cell monoclonal expansion and plasma cell dyscrasias. There we reported a case with a 20-year clinical history of PNH. Lately diagnosis of Waldenström macroglobulinemia with the offered evidences of bone marrow examination, flow cytometry and immunofixation electrophoresis. T cell monoclonal expansion was established by polymerase chain reaction. Meanwhile the decreased expression of CD55 and CD59 on neutrophils and erythrocyte were obvious observed. Here we describe the diagnostic evaluation of this patient and provide a brief review of such clonal disorder.

Entities:  

Keywords:  Monoclonal T cell proliferation; Paroxysmal nocturnal hemoglobinuria; Waldenström macroglobulinemia

Year:  2014        PMID: 25332585      PMCID: PMC4192199          DOI: 10.1007/s12288-014-0337-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  14 in total

1.  Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.

Authors:  Michael J Borowitz; Fiona E Craig; Joseph A Digiuseppe; Andrea J Illingworth; Wendell Rosse; D Robert Sutherland; Carl T Wittwer; Stephen J Richards
Journal:  Cytometry B Clin Cytom       Date:  2010-07       Impact factor: 3.058

2.  Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Lucia Gargiulo; Sonia Lastraioli; Giannamaria Cerruti; Martina Serra; Fabrizio Loiacono; Simona Zupo; Lucio Luzzatto; Rosario Notaro
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

3.  Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study.

Authors:  Susan Bell Nyland; Daniel J Krissinger; Michael J Clemente; Rosalyn B Irby; Kendall Thomas Baab; Nancy Ruth Jarbadan; Lubomir Sokol; Eric Schaefer; Jason Liao; David Cuthbertson; Pearlie Epling-Burnette; Ronald Paquette; Alan F List; Jaroslaw P Maciejewski; Thomas P Loughran
Journal:  Leuk Res       Date:  2012-03-02       Impact factor: 3.156

4.  Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias.

Authors:  John Meletis; Evangelos Terpos; Michalis Samarkos; Christos Meletis; Effie Apostolidou; Veroniki Komninaka; Konstantinos Korovesis; Konstantinos Anargyrou; Olga Benopoulou; Despina Mavrogianni; Eleni Variami; Nora Viniou; Konstantinos Konstantopoulos
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

Review 5.  Paroxysmal nocturnal hemoglobinuria from bench to bedside.

Authors:  Jeffrey J Pu; Robert A Brodsky
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

6.  Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome.

Authors:  Marcin W Wlodarski; Lukasz P Gondek; Zachary P Nearman; Magdalena Plasilova; Matt Kalaycio; Eric D Hsi; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-04-13       Impact factor: 22.113

7.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

Review 8.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

9.  Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.

Authors:  Régis Peffault de Latour; Jean Yves Mary; Célia Salanoubat; Louis Terriou; Gabriel Etienne; Mohamad Mohty; Sophie Roth; Sophie de Guibert; Sebastien Maury; Jean Yves Cahn; Gerard Socié
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

10.  The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  David J Araten; Lucio Luzzatto
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.